Skip to main content
PharmaTher Holdings Ltd. logo

PharmaTher Holdings Ltd. — Investor Relations & Filings

Ticker · PHRM ISIN · CA71716H1082 LEI · 529900PIPSZ1ZSWF3A21 CSE Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-11-24 Regulatory Filings
Country CA Canada
Listing CSE PHRM

About PharmaTher Holdings Ltd.

https://www.pharmather.com/

PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that PharmaTher Holdings Ltd. has applied for FDA Orphan Drug Designation for ketamine to treat a rare neurological disorder, Status Epilepticus. It discusses the company's strategy, the nature of the disease, and regulatory incentives related to orphan drug status. There are no financial statements, no detailed financial performance data, no management discussion of financial results, no voting results, no legal proceedings, no merger or acquisition details, and no regulatory certifications. The document is a corporate announcement about a regulatory application and drug development status, typical of a general regulatory announcement or news release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any other specific financial or governance filings. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length (6804 characters) and content confirm it is not a brief report publication announcement or a short notice but a full announcement. Confidence is high due to clear content and absence of financial or governance report elements.
2021-11-24 English
News release - English.pdf
Regulatory Filings
2021-11-11 English
Management information circular - English.pdf
Regulatory Filings
2021-11-05 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Voting Instruction Form (VIF) for the Annual General Meeting (AGM) of PharmaTher Holdings Ltd. It includes details about the meeting date, proxy appointment, resolutions to be voted on (such as election of directors and appointment of auditor), and instructions for voting. It also references the availability of financial statements and MD&A but does not contain the financial statements or detailed report itself. This type of document is used to solicit votes from shareholders prior to the AGM and is not the AGM presentation or materials themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this is a Voting Instruction Form used to solicit votes and provide voting instructions rather than the actual voting results, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length (6713 characters) and content confirm it is not a brief announcement but a detailed proxy solicitation form.
2021-11-05 English
Notice of meeting - English.pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) of shareholders for PharmaTher Holdings Ltd. It details the date, time, location, and agenda of the AGM, including receiving audited financial statements, electing directors, appointing auditors, and other business. It also includes proxy voting instructions and COVID-19 related attendance guidance. There is no actual financial data or report content, only the announcement and procedural information for the AGM. Therefore, this document fits the category of AGM Information (AGM-R). The document length is over 6000 characters, which is consistent with a detailed notice but not a full report.
2021-11-05 English
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for an Annual General Meeting (AGM) of PharmaTher Holdings Ltd. It includes instructions for appointing a proxy to vote on behalf of shareholders at the AGM, details about the meeting date, voting options, and resolutions to be approved such as election of directors and appointment of auditor. It also references the availability of financial statements but does not contain any financial data or report itself. This type of document is used to solicit votes and provide voting instructions for the AGM, which fits the definition of AGM Information (AGM-R).
2021-11-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.